Aurobindo Pharma witnessed an 8.6% YoY increase in net profit, reaching Rs 817 crore in Q2 FY25, driven by robust sales in ...

Aurobindo Pharma's Hyderabad-based biosimilars facility receives GMP certification from the European Medicines Agency, paving ...

Hyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has received a GMP ...

CuraTeQ Biologics' EMA GMP certification marks a key milestone in Aurobindo Pharma's expansion into biosimilars, with three ...

Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1475 in its research report ...

Aurobindo Pharma Ltd is quoting at Rs 1265.85, down 4.65% on the day as on 12:59 IST on the NSE. The stock jumped 29.25% in last one year as compared to a 24.11% rally in NIFTY and a 43.47% spurt in ...

Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise in con ...

Aurobindo Pharma posted an 8.6 per cent increase in net profit for the second quarter of fiscal year 2025, reaching Rs 817 ...

Aurobindo Pharma witnessed a nearly 9% surge in consolidated net profit for Q2FY25, reaching Rs 817 crore. This growth was fueled by an 8% rise in consolidated revenue, driven by a strong ...

Aurobindo Pharma's CuraTeQ Biologics receives EMA GMP certificate for biosimilars, paving way for European approvals of three ...

F&O data shows, on Friday Aarti Industries, Aurobindo Pharma and Trent saw a dip in share price alongside rise in open ...

Aurobindo Pharma’s revenue was in-line with our estimates. However, EBITDA and Adj. PAT missed our estimates due to higher ...